“If you ask people what they prefer, a component on their skin from whale vomit, or resin from a fragrantly-smelling tree, they may not say the first choice.” said Joerg Bohlmann, a professor at the University of British Columbia.    — Reuters

VANCOUVER: A product from fir trees and yeast may soon replace ambergris, a kind of whale barf, to make expensive perfume, scientists said Thursday.

For centuries, perfume makers have prized ambergris for its ability to prevent scent from dissipating.

The wax-like substance is secreted by sperm whales to protect their digestive systems from sharp objects. When the animals vomit, the ambergis reacts with salty ocean water and eventually washes ashore in chunks that can look like rocks.

Featured in Herman Melville's novel “Moby Dick,” it is a stuff of legend that still garners small fortunes for those who find it on the shores of the Atlantic, Pacific andCaribbean.

Scientists have long sought alternatives for industrial uses because ambergris is rare, costly at $10,000 a kilogram, and could “be a factor in whale hunting,” Joerg Bohlmann, a professor at the University of British Columbia, told AFP.

Bohlmann says cis-abienol, a component of sage and fir trees, can serve the same purpose as ambergris in scented products -- but until now isolating it from the rest of the sage or fir plant has been difficult.

“We've now discovered that a gene from balsam fir is much more efficient at producing such natural compounds, which could make production of this bio-product less expensive and more sustainable,” Bohlmann said in a statement.

The gene research, by Bohlmann and his colleague Philipp Zerbe, was published Thursday in the Journal of Biological Chemistry.

Bohlmann said the gene can now be introduced into yeast and grown on a large scale to produce cis-abrienol.

Bohlmann said he expects consumers will prefer the plant-based product to ambergris. “If you ask people what they prefer, a component on their skin from whale vomit, or resin from a fragrantly-smelling tree, they may not say the first choice.”

The University of British Columbia will license a bio-tech company to commercialize the product, he told AFP.

Opinion

Editorial

Growth to stability
Updated 29 Apr, 2026

Growth to stability

THE State Bank’s decision to raise its key policy rate by 100 basis points to 11.5pc signals a shift in priorities...
Constitutional order
29 Apr, 2026

Constitutional order

FOLLOWING the passage of the 26th and 27th Amendments, in 2024 and 2025 respectively, jurists and members of the...
Protecting childhood
29 Apr, 2026

Protecting childhood

AN important victory for child protection was secured on Monday with the Punjab Assembly’s passage of the Child...
Unlearnt lessons
Updated 28 Apr, 2026

Unlearnt lessons

THE US is undoubtedly the world’s top military and economic power at this time. Yet as the Iran quagmire has ...
Solar vision?
28 Apr, 2026

Solar vision?

THE recent imposition of certain regulatory requirements for small-scale solar systems, followed by the reversal of...
Breaking malaria’s grip
28 Apr, 2026

Breaking malaria’s grip

FOR the first time in decades, defeating malaria in our lifetime is possible, according to WHO. Yet in Pakistan,...